Rare diseases
Investigational molecules
Locations
Study on the Effectiveness of Durvalumab and Bevacizumab with TACE in Patients with Localized Liver Cancer
SpainStudy of Bemarituzumab with Chemotherapy and Nivolumab in Untreated Advanced Gastric and Gastroesophageal Junction Cancer Patients with FGFR2b Overexpression
SpainStudy of Sacituzumab Govitecan, Zimberelimab, and Domvanalimab for Patients with Muscle Invasive Bladder Cancer Ineligible for Cisplatin Chemotherapy
SpainStudy on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer
SpainStudy on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors
SpainStudy on Talquetamab and Tocilizumab for Patients with Relapsed or Refractory Multiple Myeloma
SpainStudy on the Effectiveness of Autogene Cevumeran in Patients with ctDNA Positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
SpainStudy Comparing Abemaciclib and Fulvestrant with Placebo and Fulvestrant for Patients with Advanced or Metastatic Breast Cancer After Previous Treatment
SpainStudy on the Safety and Effectiveness of Vepdegestrant and Samuraciclib for Adults with ER+ Advanced or Metastatic Breast Cancer
SpainStudy on the Safety and Effects of Englumafusp Alfa with Obinutuzumab and Glofitamab for Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
SpainStudy of Nivolumab and Ipilimumab for Patients with Advanced Liver Cancer (Hepatocellular Carcinoma) as First-Line Treatment
SpainStudy on Atezolizumab with Platinum-Based Chemotherapy for Patients with Early-Stage Resectable Non-Small Cell Lung Cancer
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
